Stay updated with breaking news from Jane Meisel. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Breast cancer drugs and cell therapies were prominent in this year’s annual meeting of the American Society of Clinical Oncology. Here’s a recap of some of the news highlights from the biggest cancer conference of the year.
During the annual meeting of the American Society of Clinical Oncology, AstraZeneca and Daiichi Sankyo reported pivotal clinical trial data showing that their partnered cancer drug Enhertu can treat a group of patients previously thought to be out of reach for a targeted therapy. The results suggest use of this FDA-approved drug could significantly expand to more breast cancer patients.
A company whose goal is to identify those at risk for cancer has developed a way to screen for more than 60 cancer susceptibility genes. The work is being done at Emory Medicine’s department of human genetics. GPB’s Ellen Eldridge has more. Caption Young, Black women are disproportionally affected by breast cancer, which is associated with the BRCA genes. Credit: Photo by Godisable Jacob from Pexels A national public health initiative based out of Emory University School of Medicine’s Department of Human Genetics recently announced a new program that offers at-home test...